We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Midatech Pharma Plc | LSE:MTPH | London | Ordinary Share | GB00BNGF1L75 | ORD GBP0.02 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 18.00 | 17.00 | 19.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
29/7/2020 17:07 | They got the placing stock that's all27p placing price is slowly drifting towards this | jayminpatel1 | |
29/7/2020 17:03 | Increased holding RNS just after the close !!! | parsons4 | |
29/7/2020 10:18 | This share is great. Sell at the height of euphoria, wait a week or two, buy back when the euphoria subsides :-) wait for the next spike and sell again. :-) | hodhasharon | |
28/7/2020 10:52 | I've just had EQT tipped to 8p. Does anyone hold EQT here? Want to do a bit of digging before getting in. | hodhasharon | |
28/7/2020 10:41 | DNL = RALLLYYYYYYYYYYYYYYY DNL =3x Approvals expected during next 2 months including an Orphan Drug with FDA decision on September 29 = CHEAPEST UK Biotech a potential 500%++ GEM Diurnal Group (DNL) = MCap £38 M / Cash £15 M or enough untill early 2022 / LOTS of BIG milestones on the way = Still the MOST attractive and CHEAPEST pharma stock in UK has potential to run toward 200p very fast especially on approval of Alkindi in USA (expected in September) and Chronocort in Europe (expected in Q1 ) =STRONG BUY AGGRESSIVE a sleeping giant here .GL Market Cap £38 million Cash £15 million Price 30p Alkindi approval in Australia expected this Quarter Alkindi approval in Israel expected this Quarter FDA decision for Alkindi on September 29 EMA Decision for Chronocort expected in early Q1 2021 | ih_752952 | |
28/7/2020 10:28 | It looks like the share price has now steadied at 36 p. I think this is a turning point where it climbs up slowly towards 40-50 p range. | kingston78 | |
27/7/2020 17:32 | Just look at the late trades | shujja1 | |
27/7/2020 16:33 | Lot of big buyers today 50000 , 100000. Pepole who did not get in to the placing . Someone is Accumulating. let's see what happens in the US tonight . | shujja1 | |
27/7/2020 14:14 | Yep fully funded to last quarter of 2021...no funding issues now, next positive RNS and we will leave these levels for good. | zen12 | |
27/7/2020 13:22 | strange level 2 activity with buys being fulfilled at 36p | paddyfool | |
27/7/2020 13:03 | Offcourse, £5m shares taken a drop of hat...and now fully funded to 2022. And plenty in the pipeline with 2 £billions mkt cap Global Phama partners. | invester2010 | |
27/7/2020 12:38 | Nasdaq pre-market up 2.5%This is essentially good news ! | bckttsim | |
27/7/2020 12:21 | spanish laod already paid off. Current cahs ow $15M ....mkt cap £15! :) Now woting with 2 gloale phama's and still on sale (informally). majaor trail results to come through o one product. One product better than Novatis by 50%. No wonder big Phama's interested in MTPH. Realistic mkt cap £60-£100M....200-300 What not like at here. by/hod and be paitent. Now how £5m shares taken with 2 hours for 1st rns and then 2nd. Rest all just noise. | invester2010 | |
27/7/2020 11:09 | Slowly clawing its way back up. | escapetohome | |
27/7/2020 10:40 | But how about Spanish loan - does it not have to be repaid? If so could make a significant hole in the fund raise - Even with broker overage option. | pugugly | |
27/7/2020 10:34 | Inside. share price dictates more than what meets the eye and the other point you made subscription about funding they had 2.2 million raised another 5.25 million. | shujja1 | |
27/7/2020 10:20 | shujja1 - Where is your evidence that they are fully funded by 2 big pharmas = Not that I can see in any rns - If they were why did they have to raise funds? Can you point to which rnses supports "fully funded" statement? Or were you inside? | pugugly | |
27/7/2020 09:36 | Fully funded two big pharma's as partners. what is there not to like . | shujja1 | |
27/7/2020 09:28 | Anybody reading this thread and the above 2 clowns and believing anything they write should quit this game instantly. | dave4545 | |
27/7/2020 09:20 | We might finish blue today, any other thoughts? | miahkaysor | |
27/7/2020 08:50 | Oh well , a profitable venture for me all the same. Im stuck with a few, but only by my careful management of my position and by not beingtoo greedy, this was a. Suceess. £4000 ahead. | escapetohome | |
27/7/2020 08:21 | Making a strong recovers. Placees to hold pending news? | escapetohome | |
27/7/2020 08:21 | The base (where your risk is) is 27p. A lot of upside, not much downside. Risk/reward looks good to me. | hodhasharon | |
27/7/2020 08:20 | Explains last weeks drop perfectly from 86 - 30, then 30-51, and 51-36...likely placing already forward sold! | zen12 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions